E2F1-driven cholesterol synthesis via the SND1/ACLY axis potentiates malignant progression in prostate cancer.

AIM: This study aimed to clarify the mechanisms of E2F transcription factor 1 (E2F1) in the Cholesterol (CHOL) synthesis of Prostate cancer (PCa). METHODS: CHOL component content was detected using a commercial test kit. The interaction between E2F1…

Preview only. Read the full abstract at the source